My colleagues and I have written previously about the promise and potential of comparative effectiveness research (CER) and the work of the Patient Centered Outcomes Research Institute (PCORI), but also of the challenges in defining the objectives of this research. Will CER affect clinical guidelines and practices or to simply identify gaps in medical knowledge and research as it moves forward? How can we best ensure, that the information that emerges from CER will be useful in improving patient care?
As summer drew to a close this year we learned with great sadness of the passing of Dr. Robert Fogel, a brilliant Nobel laureate who in recent years focused on the economics of aging. Dr. Fogel concluded from his analysis of historical and physiological data that we are experiencing an acceleration of human evolution that is biological in nature but not necessarily genetic. People are taller, heavier, and longer-lived due to enhanced living conditions and technological advances.
The Patient Centered Outcomes Research Institute (PCORI) held a roundtable today on “implementation and dissemination” of PCOR findings. The presentations in the early part of the day focused on methods for implementation and dissemination used by the research community, primarily by the Agency for Health Research and Quality (AHRQ), as a starting point for designing a framework or blueprint to carry forward the results of PCORI-funded research.
Earlier this month the Centers for Medicare & Medicaid Services (CMS) released a draft decision on coverage of Beta Amyloid Positron Emission Tomography (PET) in dementia and neurodegenerative disease. CMS’ preference is only to provide one scan per individual if that person is enrolled in a clinical trial and not to provide coverage in the clinical setting for others with dementia or neurodegenerative diseases until further evidence is developed supporting how Beta Amyloid PET improves health outcomes.
To quote Jennifer Lopez ,“C’mon people, let’s get loud!” Hang up your lab coat, leave your pad folios and ipads behind, and dust off your protest sign, it’s time to make some noise for medical research!
you are not alone! Comparative effectiveness research (CER) is a tool that can have a significant effect on those receiving health care, particularly older Americans. When used correctly, CER can help ensure that seniors facing illnesses receive the best care for their condition. However, many open questions remain around this critical issue.
Petitions are now in vogue and far be it for us to miss the bandwagon, especially when the White House website is hosting petitions on everything from letting Texas secede to deporting CNN's Piers Morgan. And now, a particularly meaningful petition to those of us at the Alliance for Aging Research has recently cropped up. This Alzheimer's petition holds the White House’s and Congress’ feet to the fire on the goals of the first national Alzheimer’s plan—and I am asking you to sign it.
This week the Alliance for Aging Research and the U.S. Administration on Aging (AoA) released a new white paper titled Translating Innovation to Impact: Evidence-based interventions to support people with Alzheimer's disease and their caregivers at home and in their communities. The white paper was written by Katie Maslow, MSW, Scholar-in-Residence at the Institute of Medicine, but the findings in the paper are the result of a review of the state of the art of non-pharmacological treatments and care practices that began with a public-private meeting on June 28, 2012.